| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Subunit Contributes to Delayed Rectifier K+ Currents in Myocytes From Rabbit Corpus Cavernosum





From the Departments of * Physiology and
Biophysics,
Gastroenterology and Hepatology,
and
Urology, Mayo Clinic, Rochester,
Minnesota.
| Correspondence to: Simon J. Gibbons, PhD, Department of Physiology and Biophysics, Mayo Clinic, Guggenheim 8, 200 First St SW, Rochester, MN 55905. |
| Received for publication May 15, 2002; accepted for publication June 17, 2002. |
| Abstract |
|---|
|
|
|---|
-dendrotoxin (200 nM), a Kv1
channel blocker, had no effect. The nucleotide sequence of K+
channel subunits was determined by polymerase chain reaction-based cloning
techniques using RNA derived from cavernosal muscle strips and single
identified myocytes. Molecular cloning techniques identified the full-length
sequence of the rabbit ortholog of the Kv2.2
subunit. This sequence
contains 911 amino acid residues and is 92% identical to the recently revised
human Kv2.2 sequence. Identified cavernosal myocytes of the type used in
physiological recordings expressed Kv2.2 messenger RNA. We conclude that Kv2.2
subunits contribute to whole-cell currents in rabbit canvernosal
myocytes. Further, Kv currents play a role in regulating membrane
potential and hence excitability in rabbit cavernosal myocytes.
Key words: Penile erection, potassium channels, patch clamp techniques, smooth muscle, molecular cloning
|
An increasing amount of literature is available on the actual ionic currents in cavernosal smooth muscle cells from both explant, cultured myocytes, and freshly dissociated cells. For example, the large-conductance Ca2+-activated K+ channel has been studied in some detail, particularly in cells from healthy rabbits (Malysz et al, 2001a) and from humans with erectile dysfunction (Fan et al, 1995). However, cavernosal myocytes express many types of ionic conductances and the description of these currents is still incomplete. Ion channels represent excellent potential targets for therapeutic intervention in treatment of erectile dysfunction because of their diverse molecular makeup. Voltage-dependent K+ (Kv) currents have been identified and their properties have been studied in many different types of smooth muscle cells (Beech and Bolton, 1989; Edwards and Weston, 1990; Farrugia et al, 1993). Kv channels are important determinants of the membrane potential and have been shown to contribute to the regulation of contractility in smooth muscle cells (Thornbury et al, 1992; Zhang et al, 1993; Yuan et al, 1995).
Voltage-sensitive K+ channels are composed of
and ß
subunits arranged in a tetrameric structure around a central ion-selective
pore. The
subunits are typically sufficient to form a functional
channel in expression systems. The ß subunits cannot form functional
channels, but they modify the properties of coexpressed, functional
subunits. Work on flies and mammals has identified 4 distinct subtypes of Kv
subunits, and these have been given the systematic names of Kv1
(shaker), Kv2 (shab), Kv3 (shaw), and Kv4
(shal). A number of nomenclatures have been coined, with the Kv2
subunits also being referred to as drk or KCNB
(Conley and Brammar, 1999). The
identification of Kv channel subunits is further complicated by the
cloning of several members of each family of
subunits with, for
example, two different Kv2 genes identified in tissues of humans, mice, rats,
and dogs. In addition, a number of so-called "silent"
subunits have been cloned from several different species, and these also
appear to contribute to the ion channel proteins in a number of cell types.
Until recently, Kv2 subunits from rabbits had not been identified, although a
rabbit Kv2.1 sequence has recently been added to GenBank (accession number
AF266507). The rabbit has been widely used as a model for studying the
physiology and pathology of erectile function; therefore, one goal of the
present investigation was directed at the necessary molecular identification
of K+ channel subunits in rabbit cavernosal myocytes.
Rabbit corpus cavernosum smooth muscle cells express a delayed rectifier voltage-sensitive K+ current (Malysz et al, 2001a). The biophysical properties of the current have been characterized and it appears that the Kv current contributes to the membrane potential of cavernosal myocytes. Therefore, Kv channel regulation could be an important contributor to the process of penile erection.
Many compounds, in addition to their primary sites of action, inhibit
Kv currents with varying degrees of selectivity. These compounds
include the dissociative anesthetic phencyclidine
(Frey et al, 2000) and the
appetitesuppressant drug (+)-fenfluramine
(Weir et al, 1996; Patel et al, 1997). In
addition, Kv currents in many cell types can result from the
expression of several different channel proteins within a given cell.
Consequently, nonselective inhibitors, such as 4-aminopyridine (4-AP), have
bimodal concentration response curves for blocking whole-cell currents (eg,
Baker et al, 1993; Himmel et al, 1999). However,
the differences in sensitivities to 4-AP cover a narrow concentration range
and have required the identification of more selective compounds to make it
feasible to do pharmacological profiling of Kv currents in a given
cell type. Some such Kv-selective compounds have become available
quite recently. These compounds, derived from snake and spider venoms, include
-dendrotoxin, which blocks some Kv1 channel subunits
(Harvey, 2001), and hanatoxin,
which blocks Kv2 channel subunits (Swartz
and MacKinnon, 1997a;
Kaczorowski and Garcia,
1999).
In this study, we tested the effects of several inhibitors of Kv
currents on the delayed rectifier K+ current in rabbit cavernosal
myocytes. We used the information from these studies to further assess the
contribution of Kv currents to the membrane potential of cavernosal
myocytes. Furthermore, we have identified Kv channel
subunit messages
that likely form ion channel proteins that contribute to these whole-cell
currents. Molecular cloning techniques were used to confirm the conclusions of
the physiological and pharmacological approaches, resulting in the
identification of a rabbit ortholog of a mammalian Kv channel
subunit (Kv2.2) in corpus cavernosum smooth muscle. Some of this work
has been previously presented in abstract form
(Malysz et al, 2001b).
| Materials and Methods |
|---|
|
|
|---|
Whole-Cell Voltage Clamp Recordings![]()
Conventional whole-cell patch clamp measurements were made at room
temperature (22-24°C) in a custom-designed 0.5-mL recording chamber. Glass
pipettes were coated with elastomer (R-6101; Dow Corning, Midland, Mich) and
fire-polished to form electrodes with typical resistances of 2-6 M
. The
seal resistance between the patch and the pipette was 2-10 G
. During
recordings, the holding voltage was -70 mV, with voltage steps of between -80
mV and +30 mV for 200 msec using 10 mV increments. Iberiotoxin (100-200 nM)
was included in the recording solution for every experiment to inhibit the
large conductance K+ current (BK) that is activated at membrane
voltages more positive than +30 mV in these cells
(Malysz et al, 2001a).
Recordings were made from the cells characterized as type II cavernosal
myocytes by virtue of the expression in the cells of not only a BK current,
but also a significant component of outward, voltage-sensitive K+
current (KV) (Malysz et al,
2001a). We define type II myocytes as cells in which the outward
current at +30 mV constitutes
6% of the outward current detected at +80
mV. This sets an objective standard for the choice of the cells under study
and was chosen because this is the dividing point between the 2 populations of
cells identified in our previous studies (see
Malysz et al, 2001a for
details). Type I myocytes express very little KV-like current. Data
were collected using an Axopatch 200A amplifier, Digidata 1200 interface, and
pCLAMP 8 software from Axon Instruments (Union City, Calif). Data were sampled
at 5-10 KHz and filtered at 2 KHz. A series resistance compensation of 70%-80%
was applied to each recording. The pipette solution was a standard KCl-based
intra-cellular solution buffered to pH 7.2 with Hepes-KOH and a osmolarity of
275 mOsm (135 mM KCl, 4 mM MgCl2, 3 mM Na2ATP, 2 mM
Li2GTP, 2 mM ethyleneglycotetraacetic acid, and 10 mM Hepes). The
extracellular solution had an osmolarity of 270 mOsm and contained
physiological concentrations of the standard solutes (146 mM NaCl, 4.7 mM KCl,
2 mM CaCl2, and 5 mM Hepes) buffered to pH 7.35 with Hepes-KOH. All
drugs and toxins were dissolved in the extracellular solution and applied
directly to the bath.
Cloning of Rabbit Kv2 (Shab) Orthologs From Corpus Cavernosum![]()
Rabbit Kv2 orthologs were cloned from total RNA extracted from strips of
corpus cavernosum tissue and from brain. After the animals were killed, the
corpus cavernosum was placed immediately into RNAlater (Ambion, Austin, Tex)
to preserve RNA in experimental samples. The strips of tissue were removed and
cut into small pieces for homogenization in the extraction buffer, then total
RNA was extracted using a guanidinium thiocyanate-phenol-chloroform-based kit
(Totally RNA, Ambion). First-strand complementary DNA was synthesized from 4
µg of total RNA using Moloney murine leukemia virus (MMLV) reverse
transcriptase (Life Technologies Inc, Gaithersburg, Md) with a mixture of
random hexamers and oligo(dT) as the primers (Mayo Molecular Core, Rochester,
Minn). Rabbit brain first-strand complementary DNA (cDNA) was synthesized by
the same methods.
Two pairs of degenerate oligonucleotide primers were designed for PCR
amplification of Kv2-like K+ channel
subunits. One pair was
based on conserved regions from an alignment of human, murine, rat, and canine
Kv2.1 sequences (Kv 2.1deg; Table
2). The other pair of primers was derived from an alignment of
human Kv2.1 with human Kv2.2 (hKv2 deg;
Table 2). These primers were
used to amplify products from both rabbit penis and rabbit brain RT-DNA using
platinum Taq DNA polymerase (Life Technologies) and a touchdown PCR
protocol that was run for 35 cycles of amplification. The products were
separated on a low-melt agarose gel, and single bands were excised for cloning
into the pCR2.1 plasmid vector using the TOPO-TA protocol (Invitrogen,
Carlsbad, Calif). Automated DNA sequencing of both strands of the clones
confirmed the identity of the partial sequences obtained by this method (Mayo
Molecular Core).
|
The full-length sequence of rabbit Kv2.2 was obtained with the SMART-RACE technique (Clontech, Palo Alto, Calif) using gene-specific primers for PCR amplification from the RT reaction (GSP; Table 2). The PCR products were purified, cloned, and sequenced as described above for obtaining the initial, incomplete sequences. At least 4 independent overlapping clones were obtained and sequenced in order to confirm the correct sequence of the gene products.
Amplification of Rabbit Kv2.2 From Identified Single Cavernosal
Myocytes![]()
We tested for the expression of K+ channel
subunits in
identified single rabbit cavernosal myocytes by RT-PCR using oligonucleotide
primers specific for the identified sequence of rabbit Kv2.2 (Rb2_2out and
Rb2_2in; Table 2). Identified
cells were collected in RNAase-free microcentrifuge tubes containing a carrier
molecule (0.5 µg transfer RNA) and 10 µg of proteinase K
(Lewis, 1999) and then
immediately frozen on dry ice. Cells were lysed by incubation at 90°C for
10 minutes, 50°C for 30 minutes, then 95°C for 10 minutes. The RT was
primed with a mixture of random hexamer and oligo(dT) primers, and used a
modified MMLV RT (Superscript, Invitrogen). The product of the RT reaction was
then diluted with a buffer containing the primers and polymerase enzyme for
amplification (GeneAMP Gold, PE Applied Biosystems, Foster City, Calif). All
PCR products were purified from the agarose gel using a standard procedure
(Qiaquick, Qiagen, Valencia, Calif) and sent to the Mayo Molecular Core
facility for sequencing to confirm their identity.
Materials![]()
Iberiotoxin, (+)-fenfluramine, 4-AP, and
-dendrotoxin were purchased
from Sigma Chemical Company (St Louis, Mo) and Grammostola spatulata
venom was from Spider Pharm (Yarnell, Ariz). G. spatulata has been
recently reassigned to the Phrixotricus genus, but we have used the
nomenclature that is established in the biomedical literature. Hanatoxin was a
gift from Dr Kenton J. Swartz at the National Institute of Neurological
Disorders and Stroke in Bethesda, Md. The toxins were dissolved in
extracellular solution at 1-2 µM and either diluted to the working
concentration or frozen (-20°C) as stocks for future use. G.
spatulata venom was diluted in the extracellular bath solution at the
ratio of 1:100 (v/v). All other compounds were purchased from Sigma or Fisher
Scientific (Fairlawn, NJ).
Statistical Analysis![]()
Determination of statistically significant changes in KV
currents was done with the Student's t test for single comparisons or
analysis of variance (ANOVA) using a Tukey-Kramer posttest for comparison of
more than 2 data sets using the Graphpad Instat computer package (GraphPad
Software Inc, San Diego, Calif). Data are shown as means ± SEM with
P < .05 considered to be statistically significant. SEM is the
standard error of the mean and n is the number of independent experiments,
each from a different cell.
| Results |
|---|
|
|
|---|
), and recordings could be continued for up to 1
hour with little apparent alteration in membrane integrity. Thus, it appears
that the cells were healthy and metabolically stable. To determine the effect of modulation of KV channels on cavernosal outward currents and membrane potential, the responses to 4-AP (1-10 mM) were examined. 4-AP, a nonselective K+ channel blocker, inhibited the KV currents in cavernosal myocytes in a concentration-dependent manner (Figure 1). The effect of 4-AP was fully reversible and occurred equally at all membrane voltages. 4-AP at 5 mM inhibited 52.2% ± 2.6% of the outward current at +30 mV (n = 7) and 10 mM inhibited 57.2% ± 3.2% (n = 4). 4-AP at 5 mM therefore appeared to be the maximally effective concentration (Figure 1b). The fraction of current that was inhibited by 4-AP ("difference," Figure 1a) is similar to the slowly activating, weakly inactivating current that we have described previously (Malysz et al, 2001a) and represents approximately 55% of the total Kv current in cavernosal myocytes. 4-AP (10 mM) significantly depolarized cavernosal myocytes from -27.2 ± 2.4 mV to -13.3 ± 4.1 mV (n = 4, P < .05). The concentration of 4-AP required to block the outward K+ current in these studies is sufficient to inhibit many different types of voltage-sensitive K+ currents (Mathie et al, 1998). These data therefore provide limited information about the identity of the Kv channel subunits contributing to the outward currents in rabbit cavernosal myocytes.
|
The Kv current observed in rabbit cavernosal myocytes is characteristic of the slowly activating, delayed rectifier current that has been described in other types of smooth muscle cells, including those from several different vascular tissues. In those studies, Kv currents were inhibited by the appetite-suppressant drug (+)-fenfluramine (Redux, American Home Products, Collegeville, Pa). Therefore, we tested this compound on cavernosal myocytes (Figure 2). (+)-Fenfluramine reversibly inhibited Kv currents in rabbit cavernosal myocytes in a concentration-dependent fashion between 10 µM and 1 mM (Figure 2a). The inhibition was rapid and was not sensitive to membrane voltage. At the highest tested concentration of 1 mM, (+)-fenfluramine inhibited the outward currents by 75.3% ± 2.2% at +30 mV and caused a significant depolarization of the cavernosal myocytes (control membrane potential, -30.8 ± 5.7 mV; (+)-fenfluramine, -22.9 ± 3.2 mV, n = 5, P < .05). These results demonstrate that the (+)-fenfluramine-sensitive current is a contributor to the regulation of membrane potential in cavernosal myocytes.
|
(+)-Fenfluramine is a poorly characterized modulator of Kv
currents for further characterizing the currents; therefore, in cavernosal
myocytes, we tested several peptide toxins that have been identified as
selective blockers and gating modifiers of different types of Kv
currents.
-Dendrotoxin, an inhibitor of some Kv1-type K+
channel
subunits, did not affect the outward currents in cavernosal
myocytes and had no effect on the membrane potential of the cells (control,
-23.9 ± 4.0 mV; 200 nM
-dendrotoxin, -24.6 ± 4.4 mV, n =
7, Figure 3).
|
The weak effects of
-dendrotoxin prompted us to investigate the
effects of other known toxins that inhibit Kv currents in native
cells and heterologous expression systems. The venom from the Chilean
tarantula G. spatulata contains a peptide inhibitor of a limited
number of Kv currents. G. spatulata venom significantly
inhibited the outward currents at membrane voltages more positive than -30 mV
(Figure 4). At +30 mV, a 1:100
dilution of G. spatulata venom reduced the outward current by 54.8%
± 10% (n = 6). In addition, G. spatulata venom significantly
depolarized the membrane potential from -32.3 ± 4.9 mV to -23.4
± 4.9 mV (n = 6, P < .05, paired t test). The
current that was inhibited by the venom was typical of a delayed rectifier
K+ current and exhibited weak voltage-dependent inactivation
(difference current; Figure
4a). The effect of G. spatulata venom was rapid (less
than 30 seconds) and could not be completely reversed by washing out the bath
solution because a number of cells developed a large leak conductance after
prolonged incubation.
|
G. spatulata venom contains a number of identified inhibitors of
membrane ion channels, including hanatoxin-1, a known gating modifier of
Kv2-like channels (Swartz and MacKinnon,
1995). Given that the Kv2
subunits are components of
Kv currents in several types of smooth muscle cells
(Schmalz et al, 1998;
Hulme et al, 1999; Patel et al, 1999;
Xu et al, 1999), we tested a
small fraction of hanatoxin-1 on rabbit cavernosal myocytes. In 7 cells,
purified hanatoxin-1 (1 µM) caused a small, reversible inhibition of the
outward current (Figure 5). An
effect was observed at all voltages more positive than -10 mV (P <
.05, repeated measures ANOVA) with 27.9% ± 4.2% (n = 7) of the outward
current inhibited at +30 mV. Hanatoxin-1 is difficult to purify, and only
small quantities were available for these studies; therefore, we were unable
to determine the effects of higher concentrations. The inhibition of outward
currents by 1 µM hanatoxin-1 was not sufficient to significantly alter the
membrane potential of the cells (control, -24.3 ± 6.2 mV; 1 µM
hanatoxin-1, -21.6 ± 7.6 mV, n = 7).
|
The pharmacological sensitivity of Kv currents from rabbit
cavernosal myocytes as described above, together with the biophysical
properties of these currents described previously
(Malysz et al, 2001a), suggest
that at least a component of Kv current is mediated by a rabbit
ortholog of Kv2 (Shab) K+ channel
subunits.
Because no rabbit Kv2 sequences were available when this work was initiated,
we used degenerate oligonucleotide primers to amplify 2 products from rabbit
brain and rabbit corpus cavernosum by RT-PCR. One 1028 nucleotide product had
a 90% nucleotide sequence identity to human Kv2.1, whereas another 400
nucleotide product had a 91% identity to human Kv2.2
(Figure 6a). The full-length
sequence for rabbit Kv2.1 was published in GenBank shortly after these data
were obtained, and our 1028 nucleotide clone has >99% sequence identity to
this sequence (accession number AF266507). However, the cloning and sequencing
of the rabbit ortholog of Kv2.2 has not been reported. We obtained the
full-length sequence of rabbit Kv2.2 by 5' and 3' rapid
amplification of cDNA ends using gene-specific oligonucleotide primers based
on the sequence of the 400 nucleotide product. Several independent overlapping
clones were obtained and sequenced to produce a full-length open reading frame
of 2736 nucleotides, which has been submitted to GenBank under accession
number AY037947. This nucleotide sequence has 90% identity to the revised
sequence for human Kv2.2 (accession number AF338730) and translates into a
protein of 911 amino acid residues. The revised sequence for human Kv2.2 is
significant in one important respect; namely, the presence of an additional
cytosine nucleotide near the 3' end of the messenger RNA (mRNA)
sequence. This results in a longer open reading frame than was initially
reported for the human Kv2.2 (accession number NM004770;
Schmalz et al, 1998). We have
obtained independent confirmation that the Kv2.2 sequence published as
AF338730 is correct by the sequencing of RT-PCRamplified cDNA from
human jejunum mRNA (data not shown). The residue corresponding to this
position in our rabbit sequence is also a cytosine (see alignment in
Figure 7a). In rabbits and
humans alike, the change results in a significantly different amino acid
sequence starting at the 768th residue. Further analysis of the predicted
rabbit Kv2.2 peptide sequence revealed that it contains the amino acid
residues identified as necessary for high-affinity binding of hanatoxin
(Figure 7b; Swartz and MacKinnon, 1997b).
These residues are located on the extracellular face of the channel between
the third and fourth transmembrane spanning regions.
|
|
The cloning of Kv2.2 from rabbit corpus cavernosum indicated that this
K+ channel
subunit was expressed in the tissue but gave no
indication as to which cell type contained the actual protein. To specifically
determine whether rabbit cavernosal myocytes express Kv2.2, we used
single-cell RT-PCR amplification of mRNA from identified individual myocytes.
The cells that were collected were typical of the cells that were used for
patch clamp recording. Using 10 cells as a template, we amplified a PCR
product that was identified as Kv2.2 by sequencing
(Figure 8). This result was
duplicated in 2 additional experiments.
|
| Discussion |
|---|
|
|
|---|
subunit to the Kv channel proteins in rabbit
cavernosal myocytes. Furthermore, we have identified and cloned the rabbit
Kv2.2
subunit cDNA from cavernosal myocytes. These results are a step
toward a fuller understanding of the electrical properties of cavernosal
myocytes. Previously, this understanding was limited to biophysical
descriptions of the Kv, BK, and KATP currents in freshly
dissociated and cultured cells (Christ et
al, 1993; Fan et al,
1995,
1999;
Lee et al, 1999;
Malysz et al, 2001a). The
Kv2.2
subunit identified in rabbit cavernosal myocytes is a potential
molecular target, and hanatoxin is a selective inhibitor that can be exploited
in further studies on the contribution of Kv currents to cavernosal
contractility. The investigation proved that cavernosal myocytes do not
express some Kv channel subunits (eg, Kv1.1, Kv1.2, and Kv1.6), but there
remains the likelihood that other subunits are present and remain to be
identified. In a previous study, we determined in whole-cell voltage clamp recordings from type II cavernosal myocytes that the Kv currents in these myocytes likely regulate the resting membrane potential (Malysz et al, 2001a). In the present study, we have found further evidence for the importance of Kv currents to cavernosal myocyte excitability. 4-AP, G. spatulata venom, and (+)-fenfluramine all caused inhibition of Kv currents and significant depolarization of the membrane potential. Hanatoxin also blocked the Kv current, but the block was small and did not result in membrane potential depolarization, likely due to the low concentration used as a result of the limited availability of the toxin. The cells that were treated with hanatoxin were slightly but not significantly more depolarized than those that were treated with the other compounds, and this may also have decreased the likelihood of seeing an effect of the drug at these low concentrations. The concentration of hanatoxin used in our studies corresponded to the approximate EC50 value for inhibition of ion channel subunits expressed as homo-oligomers in heterologous expression systems, so the observed effect likely represents inhibition of less than 50% of the total hanatoxin-sensitive current. The effects of K+ channel inhibitors on membrane potential are not surprising given that Kv currents have been identified in most types of smooth muscle cells and inhibition of Kv currents alters the function of both vascular and gastrointestinal smooth muscle (eg, Michelakis et al, 1999; Frey et al, 2000). The data presented here establish that Kv currents can regulate electrical excitability in single cavernosal myocytes.
The pharmacological sensitivity of Kv currents in rabbit
cavernosal myocytes is consistent with the expression of a Kv2-like
(drk or Shab) subunit in the cells. In particular, hanatoxin
is a selective inhibitor of voltage-sensitive K+ channels that
contain certain identified amino acid residues
(Li-Smerin and Swartz, 2000), and those residues are restricted to certain Kv2 and Kv4 (Shab and
Shal) orthologs. The toxin is known to have a very low affinity for
Kv1.1, Kv1.3, Kv1.6, and Kv3.1, and is predicted to have low affinity for all
other Kv1 and Kv3 channels based on mutagenesis studies
(Li-Smerin and Swartz, 2000).
Hanatoxin is not a classical pore-blocking inhibitor but is characterized as a
gating modifier that appears to bind to a region of the ion channel on the
extracellular surface close to the voltage-sensing transmembrane spanning
region (S4) (Swartz and MacKinnon,
1997b). Hanatoxin was tested on the whole-cell current in
cavernosal myocytes because G. spatulata venom blocked the current.
G. spatulata venom contains several toxins that alter ion channel
function, including the voltage-sensitive Ca2+ channel blocker,
-grammotoxin-S1A, and the recently characterized inhibitor of
cation-selective, stretch-activated channels, GsMTx-4
(Suchyna et al, 2000). The
amount of hanatoxin in the venom is variable and was not determined for the
fractions of venom that we tested. It is also possible that there is an
additional, unidentified toxin in this venom that inhibited the Kv
currents in cavernosal myocytes; therefore, the data obtained with purified
hanatoxin are important to our observations.
The conclusion that Kv2
subunits contribute to the currents in
cavernosal myocytes is supported by the ineffectiveness of
-dendrotoxin.
-Dendrotoxin did not affect the whole cell
currents and did not depolarize the membrane potential of cells. The effects
of
-dendrotoxin have been well characterized and the concentration used
in these studies (200 nM) is sufficient to completely inhibit native currents
in neurones and glial cells as well as expressed homomeric Kv1.1, Kv1.2, and
Kv1.6 channels in heterologous expression systems
(Harvey, 2001). These data
therefore suggest that at least some types of Kv1 channel subunits do not
contribute to the Kv currents in cavernosal myocytes.
The effects of (+)-fenfluramine were intriguing because this compound is
known to block currents mediated by the Kv2.1
subunit
(Patel et al, 1997) in
addition to effects on a number of other types of Kv currents (eg,
Perchenet et al, 2001),
probably including other Kv2
subunits. (+)-Fenfluramine can have
significant effects on smooth muscle function. When used as an appetite
suppressant, the serum concentrations of (+)-fenfluramine are sufficient to
substantially inhibit Kv currents
(Michelakis et al, 1999).
Several studies have implicated Kv channel inhibition in the
effects of (+)-fenfluramine on systemic blood pressure and primary pulmonary
hypertension (Abenhaim et al,
1996). There are no published reports of the peripheral effects of
(+)-fenfluramine on erectile function, but clearly, therapeutic agents that
affect Kv channel function also have the potential to affect
erectile function.
The pharmacological data presented here suggest the presence of Kv2-like
subunits in rabbit cavernosal myocytes. The biophysical data obtained
in previous studies support these conclusions. The delayed rectifier
Kv current in type II myocytes has been characterized in detail and
its properties are consistent with the expression of a Kv2-like
subunit. The current activates in response to depolarization at rather
positive voltages (VON >-30 mV), and activation is comparatively
slow compared to neuronal Kv currents or expressed homomeric Kv
subunits (
of activation
30 msec at +30 mV) (see
Coetzee et al, 1999 and
Malysz et al, 2001a for
comparison). The current also exhibits slow and incomplete inactivation for
very positive voltage steps (35.1% inactivation after 5 seconds at +30 mV) and
rapid deactivation after membrane repolarization. It is not possible to
absolutely correlate the biophysical properties of a native current with
studies on cloned channels expressed in heterologous systems, but some general
conclusions can be drawn. Fastactivating currents (
of activation <20
msec) are usually observed in cells that express Kv1, Kv3, or Kv4
subunits. Rapid, complete, voltage-dependent inactivation of Kv
currents is characteristic of some channels containing Kv1 and all Kv4
subunits. Slow deactivation is typical of cells that express Kv3
subunits. Slowly activating, weakly inactivating currents are typical of
currents carried by expressed Kv2
subunits. Therefore, the slowly
activating, weakly inactivating, and fast-deactivating current observed in
cavernosal myocytes most resembles currents in cells that express Kv2
subunits (Patel et al, 1997;
Archer et al, 1998;
Schmalz et al, 1998). This
represents a clear overlap between the pharmacological, molecular, and
biophysical data. At least part of the Kv current has the
biophysical properties of a Kv2-like subunit, at least part of the
Kv current is inhibited by a selective blocker of Kv2 channels, and
a Kv2
subunit has been cloned from identified cavernosal myocytes. In
these respects, a putative regulator of cavernosal smooth muscle contractility
has been identified and additional, similarly detailed studies can identify
other channel proteins that have the same function.
The amplification of Kv2.2 mRNA from isolated cavernosal myocytes similar
to the cells used in the electrophysiological recordings provides further
evidence for the expression of Kv2
subunits in cavernosal smooth
muscle. The full-length Kv2.2 mRNA was cloned from tissue that probably
contained many different cell types, including fibroblasts and endothelial
cells; therefore, it was important to perform single-cell PCR on typical
cavernosal myocytes in order to specifically target the cells of interest and
to exclude this possible source of contamination. The only conclusive way to
demonstrate the contribution of Kv2.2 to the current would be to knock out the
gene in an animal model or to transiently reduce expression in cultured cells
with antisense oligonucleotides. This approach is not possible in the freshly
isolated cells that were studied in our experiments; therefore, our analysis
is restricted to pharmacological studies and single-cell PCR analysis.
It is likely that a Kv2-containing channel protein is not the only Kv
channel expressed in cavernosal myocytes because the maximally effective doses
of 4-AP and (+)-fenfluramine do not inhibit all of the whole-cell outward
current. It is doubtful that the native channel is a homomeric Kv2.2
assemblage. With respect to Kv2
subunits, they have been shown to form
hetero-oligomers with several of the "silent" Kv
subunits
such as Kv5, Kv6, or Kv9 orthologs (Patel
et al, 1997; Salinas et al,
1997; Zhu et al,
1999). Our initial investigations using oligonucleotide primers to
amplify known rabbit Kv
subunits from corpus cavernosum tissue,
indicated that one of these silent subunits, Kv9.3, is expressed in the tissue
as a whole (data not shown). We have not confirmed the expression of this
message in single myocytes and the full elucidation of the molecular
composition of Kv channels in cavernosal myocytes requires further
investigation. Smooth muscle cells in general often express the Kv1.5
subunit, which has many properties in common with Kv2 channels. However, Kv1.5
is not sensitive to hanatoxin, and the currents mediated by Kv1.5 usually show
much more rapid activation kinetics than the whole-cell current in cavernosal
myocytes. This does not definitively exclude Kv1.5 as a contributor to
whole-cell currents in cavernosal myocytes, and proper investigation of this
possibility would require the use of different selective pharmacological
agents.
The sequence of rabbit Kv2.2 is informative with respect to the
conservation of the residues critical for hanatoxin binding. Otherwise, the
main observation is that the recently revised sequence for human Kv2.2 is
preserved in this rabbit sequence. The core channel-forming sequence is almost
completely conserved, including a consensus protein kinase C-phosphorylation
site and the long C terminal amino acid sequence typical of a Kv2-like
subunit. It is interesting that the previously published clones (NM_004770)
that translate into proteins with shorter C-terminus sequences do not appear
to be functionally affected by the truncation. The proteins form functional
currents and can be coexpressed with other Kv channel subunits in heterologous
systems (Hwang et al, 1992; Schmalz et al, 1998). However,
some of the immunolocalization data should be reconsidered given that the
revised nucleotide sequence results in a C-terminus peptide sequence that is
very different from the previously published sequence of Kv2.2. It has been
indicated that the Kv2.1 C-terminus contains a signal that results in the
proximal restriction and clustering of these subunits in hippocampal neurons,
and that this signal was reported to be absent in Kv2.2
(Lim et al, 2000). Our data
would affect these conclusions because the effect of the additional amino
acids on the behavior of the proximal restriction and clustering signal has
not been tested. These observations are particularly significant for the
results obtained with the antibody raised to C-terminus amino acid residues
(eg, Hwang et al, 1993a,
b). The immunolocalization
data obtained for native channels using antibodies to the N-terminus amino
acids should not be affected by this revised peptide sequence (eg,
Epperson et al, 1999).
In summary, our data indicate that Kv2
subunits contribute to the
whole-cell currents in cavernosal myocytes. We show that blocking
Kv currents results in membrane depolarization consistent with a
role for these currents in the regulation of membrane potential. The
pharmacological and physiological data indicate that Kv2-like channels mediate
a substantial fraction of the Kv current, and these data are supported by the
molecular biology showing the presence of Kv2.2 in single cavernosal myocytes.
This Kv2.2 protein is therefore one of the likely subunits in the Kv2-like
channel protein and may play a role in regulating the contractility of the
corpus cavernosum in health and disease.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Andersson KE, Wagner G. Physiology of penile erection.
Physiol Rev.1995; 75:191
-236.
Archer SL, Souil E, Dinh-Xuan AT, et al. Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest.1998; 101:2319 -2330.[Medline]
Baker M, Howe JR, Ritchie JM. Two types of
4-aminopyridine-sensitive potassium current in rabbit Schwann cells.
J Physiol.1993; 464:321
-342.
Beech DJ, Bolton TB. Two components of potassium current activated
by depolarization of single smooth muscle cells from the rabbit portal vein.
J Physiol.1989; 418:293
-309.
Christ GJ. The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection. Urol Clin North Am. 1995;22:727 -745.[Medline]
Christ GJ, Spray DC, Brink PR. Characterization of K currents in
cultured human corporal smooth muscle cells. J Androl.1993; 14:319
-328.
Coetzee WA, Amarillo Y, Chiu J, et al. Molecular diversity of K+ channels. Ann NY Acad Sci.1999; 868:233 -285.[Medline]
Conley EC, Brammar WJ, eds. The Ion Channel Facts Book: Voltage-Gated Channels. 1st ed. London: Academic Press;1999 .
Edwards G, Weston AH. Potassium channel openers and vascular smooth muscle relaxation. Pharmacol Ther.1990; 48:237 -258.[Medline]
Epperson A, Bonner HP, Ward SM, Hatton WJ, Bradley KK, Bradley ME, Trimmer JS, Horowitz B. Molecular diversity of Kv alpha- and beta-subunit expression in canine gastrointestinal smooth muscles. Am J Physiol.1999; 277:G127 -G136.
Fan SF, Brink PR, Melman A, Christ GJ. An analysis of the maxi-K+ (KCa) channel in cultured human corporal smooth muscle cells. J Urol.1995; 153:818 -825.[Medline]
Fan SF, Christ GJ, Melman A, Brink PR. A stretch-sensitive Cl- channel in human corpus cavernosal myocytes. Int J Impot Res. 1999;11:1 -7.[Medline]
Farrugia G, Rae JL, Sarr MG, Szurszewski JH. Potassium current in circular smooth muscle of human jejunum activated by fenamates. Am J Physiol. 1993;265:G873 -G879.
Frey BW, Lynch FT, Kinsella JM, Horowitz B, Sanders KM, Carl A. Blocking of cloned and native delayed rectifier K channels from visceral smooth muscles by phencyclidine. Neurogastroenterol Motil. 2000;12:509 -516.[Medline]
Harvey AL. Twenty years of dendrotoxins. Toxicon. 2001;39:15 -26.[Medline]
Himmel HM, Wettwer E, Li Q, Ravens U. Four different components contribute to outward current in rat ventricular myocytes. Am J Physiol. 1999;277:H107 -H118.
Hulme JT, Coppock EA, Felipe A, Martens JR, Tamkun MM. Oxygen
sensitivity of cloned voltage-gated K+ channels expressed in the
pulmonary vasculature. Circ Res.1999; 85:489
-497.
Hwang PM, Cunningham AM, Peng YW, Snyder SH. CDRK and DRK1 K+ channels have contrasting localizations in sensory systems. Neuroscience.1993a; 55:613 -620.[Medline]
Hwang PM, Fotuhi M, Bredt DS, Cunningham AM, Snyder SH. Contrasting immunohistochemical localizations in rat brain of two novel K+ channels of the Shab subfamily. J Neurosci.1993b; 13:1569 -1576.[Abstract]
Hwang PM, Glatt CE, Bredt DS, Yellen G, Snyder SH. A novel K+ channel with unique localizations in mammalian brain: molecular cloning and characterization. Neuron.1992; 8:473 -481.[Medline]
Kaczorowski GJ, Garcia ML. Pharmacology of voltage-gated and calcium-activated potassium channels. Curr Opin Chem Biol. 1999;3:448 -458.[Medline]
Lee SW, Wang HZ, Christ GJ. Characterization of ATP-sensitive potassium channels in human corporal smooth muscle cells. Int J Impot Res. 1999;11:179 -188.[Medline]
Lewis RS. Store-operated calcium channels. Adv Second Messenger Phosphoprotein Res.1999; 33:279 -307.[Medline]
Li-Smerin Y, Swartz KJ. Localization and molecular determinants of
the hanatoxin receptors on the voltage-sensing domains of a K(+) channel.
J Gen Physiol.2000; 115:673
-684.
Lim ST, Antonucci DE, Scannevin RH, Trimmer JS. A novel targeting signal for proximal clustering of the Kv2.1 K+ channel in hippocampal neurons. Neuron. 2000;25:385 -397.[Medline]
Malysz J, Farrugia G, Ou Y, Szurszewski JH, Nehra A, Gibbons SJ. Expression of KV2.2 and its contribution to whole cell K+ currents in rabbit penile myocytes. Biophys J.2001b; 80:647a .
Malysz J, Gibbons SJ, Miller SM, Gettman M, Nehra A, Szurszewski JH, Farrugia G. Potassium outward currents in freshly dissociated rabbit corpus cavernosum myocytes. J Urol.2001a; 166:1167 -1177.[Medline]
Mathie A, Wooltorton JR, Watkins CS. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen Pharmacol.1998; 30:13 -24.[Medline]
Michelakis ED, Weir EK, Nelson DP, Reeve HL, Tolarova S, Archer SL.
Dexfenfluramine elevates systemic blood pressure by inhibiting potassium
currents in vascular smooth muscle cells. J Pharmacol Exp
Ther. 1999;291:1143
-1149.
Moreland RB, Hsieh G, Nakane M, Brioni JD. The biochemical and
neurologic basis for the treatment of male erectile dysfunction. J
Pharmacol Exp Ther. 2001;296:225
-234.
Padma-Nathan H, Giuliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am.2001; 28:321 -334.[Medline]
Patel AJ, Lazdunski M, Honore E. Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes. EMBO J. 1997;16:6615 -6625.[Medline]
Patel AJ, Lazdunski M, Honore E. Kv2.1/Kv9.3, an ATP-dependent delayed-rectifier K+ channel in pulmonary artery myocytes. Ann NY Acad Sci. 1999;868:438 -441.[Medline]
Perchenet L, Hilfiger L, Mizrahi J, Clement-Chomienne O. Effects of
anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5. J
Pharmacol Exp Ther. 2001;298:1108
-1119.
Salinas M, Duprat F, Heurteaux C, Hugnot JP, Lazdunski M. New
modulatory alpha subunits for mammalian Shab K+ channels. J Biol
Chem. 1997;272:24371
-24379.
Schmalz F, Kinsella J, Koh SD, Vogalis F, Schneider A, Flynn ER, Kenyon JL, Horowitz B. Molecular identification of a component of delayed rectifier current in gastrointestinal smooth muscles. Am J Physiol. 1998;274:G901 -G911.
Suchyna TM, Johnson JH, Hamer K, Leykam JF, Gage DA, Clemo HF, Baumgarten CM, Sachs F. Identification of a peptide toxin from Grammostola spatulata spider venom that blocks cation-selective stretch-activated channels. J Gen Physiol.2000; 115:5 83-598.
Swartz KJ, MacKinnon R. An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula. Neuron. 1995;15:941 -949.[Medline]
Swartz KJ, MacKinnon R. Hanatoxin modifies the gating of a voltage-dependent K+ channel through multiple binding sites. Neuron. 1997a;18:665 -673.[Medline]
Swartz KJ, MacKinnon R. Mapping the receptor site for hanatoxin, a gating modifier of voltage-dependent K+ channels. Neuron. 1997b;18:675 -682.[Medline]
Thornbury KD, Ward SM, Sanders KM. Participation of fast-activating, voltage-dependent K currents in electrical slow waves of colonic circular muscle. Am J Physiol.1992; 263:C226 -C236.
Weir EK, Reeve HL, Huang JM, Michelakis E, Nelson DP, Hampl V,
Archer SL. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit
potassium current in rat pulmonary vascular smooth muscle and cause pulmonary
vasoconstriction. Circulation.1996; 94:2216
-2220.
Xu C, Lu Y, Tang G, Wang R. Expression of voltage-dependent K+ channel genes in mesenteric artery smooth muscle cells. Am J Physiol.1999; 277:G1055 -G1063.
Yuan XJ, Tod ML, Rubin LJ, Blaustein MP. Hypoxic and metabolic regulation of voltage-gated K+ channels in rat pulmonary artery smooth muscle cells. Exp Physiol.1995; 80:803 -813.[Abstract]
Zhang L, Bonev AD, Nelson MT, Mawe GM. Ionic basis of the action potential of guinea pig gallbladder smooth muscle cells. Am J Physiol. 1993;265:C1552 -C1561.
Zhu XR, Netzer R, Bohlke K, Liu Q, Pongs O. Structural and functional characterization of Kv6.2 a new gamma-subunit of voltage-gated potassium channel. Receptors Channels.1999; 6:337 -350.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |